Ospedale Fatebenefratelli Isola Tiberina Gemelli Isola

At Ospedale Fatebenefratelli Isola Tiberina Gemelli Isola in Rome, clinical research in digestive system diseases focuses on ulcerative colitis, Crohn's disease, and other inflammatory conditions affecting the gut. These studies are designed to test new treatments and better understand how to achieve and maintain remission in chronic intestinal disease.

• Testing novel therapies for ulcerative colitis
• Evaluating treatment options for Crohn's disease
• Studying approaches to improve clinical remission and long-term disease control

The site also explores related gastrointestinal conditions such as eosinophilic gastritis, reflecting a broader interest in improving care for patients with difficult-to-treat digestive disorders.

Research in neoplasms is a major focus, with trials covering breast cancer, colorectal cancer, lung cancer, melanoma, and head and neck cancer. Many of these studies aim to improve how cancers are treated after surgery, in advanced disease, or when standard options are no longer effective.

• Evaluating new treatment strategies for advanced solid tumors
• Studying therapies for breast cancer and triple-negative breast cancer
• Assessing options for colorectal cancer and metastatic disease
• Testing treatment effectiveness in non-small cell lung cancer, small cell lung cancer, and melanoma

These trials are largely focused on improving survival, controlling disease progression, and identifying more effective personalized cancer treatments.

The site supports clinical trials in nervous system diseases, especially Alzheimer's disease and early symptomatic Alzheimer’s disease. This research is aimed at understanding whether new therapies can slow cognitive decline and support patients in the earliest stages of memory loss and dementia.

• Testing potential treatments for early Alzheimer’s disease
• Evaluating safety and long-term tolerability of new neurological therapies
• Studying whether treatment can slow clinical progression and preserve function

These studies reflect a strong interest in finding better ways to diagnose and manage progressive brain disorders before they advance further.

Clinical trials in cardiovascular diseases, nutritional and metabolic diseases, and related metabolism and immune system phenomena include studies in type 2 diabetes, acute myocardial infarction, heart failure due to ATTR amyloidosis, chronic kidney disease, and broader cardiometabolic risk reduction. The goal is to improve outcomes in patients with common and high-risk chronic illnesses.

• Testing therapies to reduce major adverse cardiovascular events
• Studying treatment effects in type 2 diabetes and cardiovascular autonomic neuropathy
• Evaluating options for chronic kidney disease progression
• Exploring new care strategies for ATTR amyloid cardiomyopathy

Research here often connects heart, kidney, and metabolic health, showing a broad interest in preventing complications across multiple organ systems.

Additional work spans respiratory tract diseases, skin and connective tissue diseases, and eye diseases. These trials involve conditions such as asthma, chronic spontaneous urticaria, and neovascular age-related macular degeneration, with a focus on improving symptom control and quality of life.

• Assessing new treatments for asthma
• Studying therapies for chronic spontaneous urticaria
• Evaluating approaches for neovascular age-related macular degeneration
• Supporting research into immune-related skin and allergy conditions

These studies broaden the research portfolio at the Rome site by addressing chronic conditions that affect breathing, skin health, and vision.